In response to congressional direction, the Department of Defense is planning to divide its existing defense acquisition office into two separate organizations. The change, which would take effect in February 2018, is predicated on the belief that it would promote technological innovation and increase efficiency.
A new report from the Congressional Research Service provides background on the move. See DOD Plan to Split Acquisition Duties, CRS Insight, August 18, 2017.
Other new and updated reports from the Congressional Research Service include the following.
Select Acquisition Reform Provisions in the House and Senate Versions of the FY2018 National Defense Authorization Act, August 21, 2017
Who Regulates Whom? An Overview of the U.S. Financial Regulatory Framework, August 17, 2017
Select Demographic and Other Characteristics of Recent U.S. Circuit and District Court Nominees, CRS Insight, August 17, 2017
The United Arab Emirates (UAE): Issues for U.S. Policy, updated August 18, 2017
U.S. Role in the World: Background and Issues for Congress, updated August 17, 2017
China Naval Modernization: Implications for U.S. Navy Capabilities — Background and Issues for Congress, updated August 18, 2017
Maritime Territorial and Exclusive Economic Zone (EEZ) Disputes Involving China: Issues for Congress, updated August 17, 2017
Comparing DHS Component Funding, FY2018: In Brief, August 21, 2017
Violence Against Members of Congress and Their Staff: Selected Examples and Congressional Responses, updated August 17, 2017
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.